http://www.yso.fi/onto/yso/p3051 ovarian cancer
ovarian cancer
Prostacyclin and thromboxane A[sub 2] in human cancers of the breast, uterus and ovary
Prognostic role of cell adhesion factors and angiogenesis in epithelial ovarian cancer
Spread of ovarian cancer after laparoscopic surgery : report of eight cases
Postmenopausal hormone therapy and risk of ovarian and primary fallopian tube cancer
Adenoviral gene therapy for ovarian cancer
Molecular genetics of lactase deficiencies
Cyclooxygenase-2 in myometrium during parturition and in ovarian carcinoma
Studies on therapeutic and prognostic factors in ovarian cancer
Gene therapy for ovarian cancer : antiangiogenic and imaging study
Oxidative stress in the pathogenesis and prognosis of ovarian cancer
Ovarian cancer-associated tumor markers CA 125 and TATI
Advanced epithelial ovarian cancer-studies on preoperative [18F]FDG PET/CT and HE4 profile during primary chemotherapy
CA 125 as a screening test for ovarian cancer
Tumor-associated trypsin inhibitor
Ovarian cancer and gene therapy : modelling, angiogenesis and targeting vascular supply
Effect of interleukin 2 on urinary excretion of degradation products of prostacyclin and thromboxane A2 in patients with ovarian cancer
Molecular and cytogenetic changes in ovarian carcinoma
Epidemiological study of the role of vitamin D in the aetiology of ovarian cancer
Chemotherapy changes the DNA ploidy in ovarian cancer
Germline mutations of BRCA1 and BRCA2 genes : founder effects and contribution to ovarian carcinoma in Finland
Biological predictors of disease progression and patient survival in epithelial ovarian cancer
Biology and molecular markers of malignant gonadal germ cell tumors
A case study of the treatment of ovarian cancer complicated by an adverse reaction
Novel functions of ErbB4 and NRG-1 in development and cancer
Prospective study of serum micronutrients and ovarian cancer : [correspondance]
Glycodelin and differentiation in endometrium and ovary : clinical aspects related to reproduction and epithelial ovarian cancer
Epithelial ovarian cancer : chemosensitivity to platinum analogues and taxanes in vitro
Type I and type III collagen metabolites and peritoneal cells in predicting the clinical outcome of epithelial ovarian cancer patients
Finnish summary.
Breast cancer-predisposing genes in Finnish breast and ovarian cancer families
Genetic predisposition to breast and ovarian cancer in Eastern Finnish population
Markers supplementing CA 125 in ovarian cancer
Activation of FGF-8 in hormonal cancer : with special reference to murine breast cancer cells and human prostate and ovarian cancer
Normal human ovary and ovarian tumors express glycodelin, a glycoprotein with immunosuppressive and contraceptive properies
Incidence of gynaecological cancers and overall and cause specific mortality of grand multiparous women in Finland
Vitamin D in human ovarian and prostate cancer
Evidence for divergence of DNA copy number changes in serous, mucinous and endometrioid ovarian carcinomas
Ovarian cancer : biological, epidemiological and clinical aspects
RAD51C a tumor suppressor in mammary and sebaceous glands
Oxidative stress in breast and gynaecological carcinogenesis
Metabolic imaging of ovarian tumors with carbon-11-methionine: a PET study
Genetic predisposition to breast and ovarian cancer : BRCA 1/2-negative families
Infertility and its treatment : association with ovarian granulosa cell tumour and impact on vascular endothelial growth factor, leptin and selected tumour markers in serum
Oncolytic adenoviruses for gynecologic cancer
Genetic changes in inherited and sporadic ovarian carcinomas by comparative genomic hyrbridization : extensive similarity except for a difference at chromosome 2q24-q32 1.
p53 protein detected by immunohistochemistry as a prognostic factor in patients with epithelial ovarian carcinoma
Matrix metalloproteinases -2 and -9 and tissue inhibitors of metalloproteinases -1 and -2 in gynaecological cancers
Women's health
Resistance of ovarian teratocarcinoma cell sphreroids to complement-mediated lysis
Human milk fat globule membrane antigens as diagnostic markers for ovarian carcinoma
Novye podhody v terapii opuholevyh zabolevanij : materialy simpoziuma, provedennogo 18 nojabrja 1986 g. v g. Moskve = New approaches in the therapy of oncological diseases : symposium in Moscow, 1986
Advanced epithelial ovarian cancer : studies on preoperative [18F]FDG PET/CT and HE4 profile during primary chemotherapy
Luteinizing hormone-releasing hormone agonist triptorelin incombination with cytotoxic chemotherapy in patients with advanced ovarian carcinoma : a prospective double blind randomized trial
Glycodelin and differentation in endometrium and ovary : clinical aspects related to reproduction and epithelial cancer
Expression of hyaluronan synthases and hyaluronidases in gynecological malignancies
Removing bias in cancer survival estimates by active follow-up and information on determinants of loss to follow-up : a study on ovarian cancer patients seen at Regional Cancer Centre, Trivandrum, India in 1989 to 1993
Summary.
In search of new prognostic molecular markers in ovarian cancer
Intravascular contrast agent in gynecologic and obstetric ultrasonography : Maija- Riitta Ordén
Human trypsinogens in the pancreas and in cancer
Molecular profiling of human endometrium and endometriosis
Prognostic significance of cell-matrix interactions in epithelial ovarian cancer
Oncolytic adenoviruses for treatment of ovarian cancer
Biology and Molecular Markers of Malignant Gonadal Germ Cell Tumors
Predisposing genes in hereditary breast and ovarian cancer
Genetic and molecular changes in serous gynecological carcinomas : comparison with other histological types, and clinical associations
Molecular Studies on Pathogenesis, Prognostic Factors, and New Treatment Options for Ovarian Granulosa Cell Tumors
Prognostic factors in ovarian carcinoma : a clinopathologic study with special reference to mitotic counts, nuclear morphometry and DNA cytometry
Transcription factor GATA4 and apoptotic TRAIL pathway in granulosa cell function and tumors
Targeting the growth of ovarian cancer cells : in vitro effect of vitamin D3 , anticancer drugs and p53 gene therapy
Quantitative histochemical analysis of carcinoembryonic antigen and mucosubstances in classification and prognostic evaluation of epithelial tumours of the ovary
Inhibins and the normal and neoplastic ovary during perimenopause
Strategies to prevent germ cell death for fertility preservation
Operative treatment of ovarian cancer and borderline tumors in different hospital categories in Finland
Molecular studies on pathogenesis, prognostic factors, and new treatment options for ovarian granulosa cell tumors
Ovarian development, function, and granulosa cell tumorigenesis : role of GATA transcription factors and anti-Müllerian hormone
Hyaluronan in cancer : regulation and consequences of hyaluronan biosynthesis
Genomic alterations in fallopian tube carcinoma : comparison to serous uterine and ovarian carcinomas reveals similarity suggesting likeness in molecular pathogenesis
Hormonal regulation of gonadal and adrenal tumorigenesis and cell ablations in transgenic mice
Ovarian cancer and gene therapy - modelling, angiogenesis and targeting vascular supply
DNA copy number changes in the stromal and epithelial cells of ovarian and breast tumours
